Literature DB >> 33097308

Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy.

Christopher F Rose1, Piero Amodio2, Jasmohan S Bajaj3, Radha Krishan Dhiman4, Sara Montagnese2, Simon D Taylor-Robinson5, Hendrik Vilstrup6, Rajiv Jalan7.   

Abstract

Hepatic encephalopathy (HE) is a frequent and serious complication of both chronic liver disease and acute liver failure. HE manifests as a wide spectrum of neuropsychiatric abnormalities, from subclinical changes (mild cognitive impairment) to marked disorientation, confusion and coma. The clinical and economic burden of HE is considerable, and it contributes greatly to impaired quality of life, morbidity and mortality. This review will critically discuss the latest classification of HE, as well as the pathogenesis and pathophysiological pathways underlying the neurological decline in patients with end-stage liver disease. In addition, management strategies, diagnostic approaches, currently available therapeutic options and novel treatment strategies are discussed. Crown
Copyright © 2020. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ammonia; Diagnosis; Hepatic encephalopathy; Management; Pathogenesis; Pathophysiology; Treatments

Year:  2020        PMID: 33097308     DOI: 10.1016/j.jhep.2020.07.013

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  34 in total

1.  Ashwagandha-loaded nanocapsules improved the behavioral alterations, and blocked MAPK and induced Nrf2 signaling pathways in a hepatic encephalopathy rat model.

Authors:  Heba M A Khalil; Islam A Khalil; Asmaa K Al-Mokaddem; Marwa Hassan; Riham A El-Shiekh; Hesham A Eliwa; Azza M Tawfek; Walaa H El-Maadawy
Journal:  Drug Deliv Transl Res       Date:  2022-06-07       Impact factor: 4.617

Review 2.  Cirrhosis-associated immune dysfunction.

Authors:  Agustín Albillos; Rosa Martin-Mateos; Schalk Van der Merwe; Reiner Wiest; Rajiv Jalan; Melchor Álvarez-Mon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-10-26       Impact factor: 46.802

Review 3.  Hepatic encephalopathy.

Authors:  Dieter Häussinger; Radha K Dhiman; Vicente Felipo; Boris Görg; Rajiv Jalan; Gerald Kircheis; Manuela Merli; Sara Montagnese; Manuel Romero-Gomez; Alfons Schnitzler; Simon D Taylor-Robinson; Hendrik Vilstrup
Journal:  Nat Rev Dis Primers       Date:  2022-06-23       Impact factor: 65.038

4.  Peroxisome proliferator-activated receptor-γ doesn't modify altered electrophysiological properties of the CA1 pyramidal neurons in a rat model of hepatic cirrhosis.

Authors:  Mahshid Tahamtan; Iraj Aghaei; Mohammad Shabani; Abbas Nazari; Vahid Pooladvand; Moazamehosadat Razavinasab
Journal:  Metab Brain Dis       Date:  2022-08-09       Impact factor: 3.655

Review 5.  Diabetes mellitus - risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis?

Authors:  Simon Johannes Gairing; Eva Maria Schleicher; Christian Labenz
Journal:  Metab Brain Dis       Date:  2022-08-24       Impact factor: 3.655

6.  Judging the value of ammonia measurement on lactulose dosing: Apples and oranges?

Authors:  Christopher F Rose; Rajiv Jalan
Journal:  Can Liver J       Date:  2021-02-24

7.  Prediction of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt treatment: a cohort study.

Authors:  Yang Yang; Sirui Fu; Bin Cao; Kenan Hao; Yong Li; Jianwen Huang; Wenfeng Shi; Chongyang Duan; Xiao Bai; Kai Tang; Shirui Yang; Xiaofeng He; Ligong Lu
Journal:  Hepatol Int       Date:  2021-05-11       Impact factor: 6.047

Review 8.  Hepatic Encephalopathy: From Metabolic to Neurodegenerative.

Authors:  Rafael Ochoa-Sanchez; Farzaneh Tamnanloo; Christopher F Rose
Journal:  Neurochem Res       Date:  2021-06-15       Impact factor: 3.996

Review 9.  Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis.

Authors:  Segundo Moran; Marlene López-Sánchez; María Del Pilar Milke-García; Gustavo Rodríguez-Leal
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

10.  Fiber scaffold bioartificial liver therapy relieves acute liver failure and extrahepatic organ injury in pigs.

Authors:  Jun Weng; Xu Han; Fanhong Zeng; Yue Zhang; Lei Feng; Lei Cai; Kangyan Liang; Shusong Liu; Shao Li; Gongbo Fu; Min Zeng; Yi Gao
Journal:  Theranostics       Date:  2021-06-11       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.